JP2017043632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017043632A5 JP2017043632A5 JP2016225290A JP2016225290A JP2017043632A5 JP 2017043632 A5 JP2017043632 A5 JP 2017043632A5 JP 2016225290 A JP2016225290 A JP 2016225290A JP 2016225290 A JP2016225290 A JP 2016225290A JP 2017043632 A5 JP2017043632 A5 JP 2017043632A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- factor
- inhibitor
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97634307P | 2007-09-28 | 2007-09-28 | |
| US60/976,343 | 2007-09-28 | ||
| US9057408P | 2008-08-20 | 2008-08-20 | |
| US61/090,574 | 2008-08-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014166333A Division JP6047127B2 (ja) | 2007-09-28 | 2014-08-19 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018033229A Division JP2018100290A (ja) | 2007-09-28 | 2018-02-27 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017043632A JP2017043632A (ja) | 2017-03-02 |
| JP2017043632A5 true JP2017043632A5 (https=) | 2017-07-27 |
| JP6300885B2 JP6300885B2 (ja) | 2018-03-28 |
Family
ID=40481812
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527220A Active JP5637561B2 (ja) | 2007-09-28 | 2008-09-26 | 第Ｘａ因子阻害剤に対する解毒剤およびその使用の方法 |
| JP2014166333A Active JP6047127B2 (ja) | 2007-09-28 | 2014-08-19 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2016225290A Active JP6300885B2 (ja) | 2007-09-28 | 2016-11-18 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2018033229A Pending JP2018100290A (ja) | 2007-09-28 | 2018-02-27 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2020042919A Pending JP2020109113A (ja) | 2007-09-28 | 2020-03-12 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2022121451A Pending JP2022153574A (ja) | 2007-09-28 | 2022-07-29 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2025008426A Pending JP2025063249A (ja) | 2007-09-28 | 2025-01-21 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010527220A Active JP5637561B2 (ja) | 2007-09-28 | 2008-09-26 | 第Ｘａ因子阻害剤に対する解毒剤およびその使用の方法 |
| JP2014166333A Active JP6047127B2 (ja) | 2007-09-28 | 2014-08-19 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018033229A Pending JP2018100290A (ja) | 2007-09-28 | 2018-02-27 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2020042919A Pending JP2020109113A (ja) | 2007-09-28 | 2020-03-12 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2022121451A Pending JP2022153574A (ja) | 2007-09-28 | 2022-07-29 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
| JP2025008426A Pending JP2025063249A (ja) | 2007-09-28 | 2025-01-21 | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 |
Country Status (26)
| Country | Link |
|---|---|
| US (8) | US8153590B2 (https=) |
| EP (4) | EP2193196B1 (https=) |
| JP (7) | JP5637561B2 (https=) |
| KR (4) | KR102069498B1 (https=) |
| CN (4) | CN101802188B (https=) |
| AU (7) | AU2008304192B9 (https=) |
| BR (2) | BRPI0816837B1 (https=) |
| CA (1) | CA2697583C (https=) |
| CY (3) | CY1118482T1 (https=) |
| DK (3) | DK3078743T3 (https=) |
| ES (3) | ES2597436T3 (https=) |
| FR (1) | FR20C1045I2 (https=) |
| HR (2) | HRP20161255T1 (https=) |
| HU (4) | HUE031647T2 (https=) |
| IL (4) | IL203993A (https=) |
| LT (3) | LT2193196T (https=) |
| MX (1) | MX2010003095A (https=) |
| NL (1) | NL301063I2 (https=) |
| NO (2) | NO2019040I1 (https=) |
| NZ (1) | NZ583944A (https=) |
| PL (3) | PL2915564T3 (https=) |
| PT (3) | PT2915564T (https=) |
| SG (1) | SG185263A1 (https=) |
| SI (3) | SI2915564T1 (https=) |
| WO (1) | WO2009042962A2 (https=) |
| ZA (2) | ZA201002039B (https=) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696352B2 (en) * | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
| MX2008014193A (es) | 2006-05-05 | 2009-03-31 | Millennium Pharm Inc | Inhibidores del factor xa. |
| KR102069498B1 (ko) | 2007-09-28 | 2020-01-23 | 포톨라 파마슈티컬스, 인코포레이티드 | 인자 Ｘａ 저해제에 대한 안티도트 및 그것을 사용하는 방법 |
| EP2364165B1 (en) * | 2008-11-14 | 2018-01-03 | Portola Pharmaceuticals, Inc. | Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents |
| WO2010071894A2 (en) | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Tfpi inhibitors and methods of use |
| PL3604510T3 (pl) | 2009-03-30 | 2025-07-28 | Alexion Pharmaceuticals, Inc. | Antidota na inhibitory czynnika xa i sposoby ich stosowania |
| PT2453910T (pt) * | 2009-07-15 | 2016-12-07 | Portola Pharm Inc | Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento |
| GB0916576D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| EP2316931B1 (de) | 2009-10-30 | 2016-12-28 | Senova Gesellschaft für Biowissenschaft und Technik mbH | Polymergekoppelte Peptidasen |
| US8742120B2 (en) | 2009-12-17 | 2014-06-03 | Millennium Pharmaceuticals, Inc. | Methods of preparing factor xa inhibitors and salts thereof |
| CA2784921A1 (en) * | 2009-12-17 | 2011-07-14 | Millennium Pharmaceuticals, Inc. | Salts and crystalline forms of a factor xa inhibitor |
| AR079944A1 (es) | 2010-01-20 | 2012-02-29 | Boehringer Ingelheim Int | Anticuerpo neutralizante de la actividad de un anticoagulante |
| AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
| TW201221128A (en) | 2010-09-01 | 2012-06-01 | Portola Pharm Inc | Crystalline forms of a factor Xa inhibitor |
| TW201240664A (en) * | 2010-09-01 | 2012-10-16 | Portola Pharm Inc | Methods and formulations of treating thrombosis with betrixaban and a P-glycoprotein inhibitor |
| WO2012098089A1 (en) | 2011-01-19 | 2012-07-26 | Bayer Pharma Aktiengesellschaft | Binding proteins to inhibitors of coagulation factors |
| FR2972114B1 (fr) * | 2011-03-01 | 2013-03-15 | Univ Grenoble 1 | Un nouveau leurre moleculaire procoagulant pour le traitement des hemophiles a ou b avec ou sans inhibiteur |
| SG193552A1 (en) | 2011-03-30 | 2013-11-29 | Boehringer Ingelheim Int | Anticoagulant antidotes |
| JP6514893B2 (ja) | 2011-09-30 | 2019-05-15 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ | 止血を調節するための組成物および方法 |
| DK2785700T3 (en) * | 2011-11-29 | 2016-06-13 | Perosphere Inc | Agent for preventing the action of anti-coagulants. |
| HK1205188A1 (en) * | 2012-02-14 | 2015-12-11 | Portola Pharmaceuticals, Inc. | Process for making recombinant antidote to factor xa inhibitor |
| US20160015793A1 (en) * | 2012-02-16 | 2016-01-21 | Portola Pharmacueticals, Inc. | Modulation of factor xa inhibitor mediated blood loss by partial and transient administration of antidote |
| WO2013141965A1 (en) | 2012-03-21 | 2013-09-26 | Baxter International Inc. | Tfpi inhibitors and methods of use |
| JP6261093B2 (ja) * | 2012-06-14 | 2018-01-17 | ポートラ ファーマシューティカルズ， インコーポレイテッド | 組み換え第Ｘａ因子誘導体の精製のための方法 |
| MX365612B (es) | 2012-07-25 | 2019-06-07 | Catalyst Biosciences Inc | Polipeptidos de factor x modificados y usos de los mismos. |
| US9200268B2 (en) | 2012-12-27 | 2015-12-01 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
| FR3000895B1 (fr) * | 2013-01-11 | 2017-02-24 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa | Utilisation d'antidotes d'inhibiteurs de la coagulation indiques dans la prevention ou le traitement de pathologies thromboemboliques |
| SG10201705189XA (en) * | 2013-01-24 | 2017-07-28 | Portola Pharm Inc | INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR Xa DERIVATIVES |
| EP2950813B1 (en) | 2013-01-31 | 2019-09-04 | Pfizer Inc | Compositions and methods for counteracting factor xa inhibition |
| FR3007410B1 (fr) * | 2013-06-21 | 2016-05-27 | Lab Francais Du Fractionnement | Facteur x depourvu de domaine gla |
| MY173548A (en) * | 2013-09-24 | 2020-02-04 | Pfizer | Fxa variant compositions |
| JP6629744B2 (ja) * | 2013-11-01 | 2020-01-15 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ | 第Ｘａ因子の半減期を延ばす組成物および方法 |
| PL3149163T3 (pl) * | 2014-05-26 | 2020-12-28 | Academisch Ziekenhuis Leiden | Białka prohemostatyczne do leczenia krwawienia |
| US10501773B2 (en) * | 2014-07-31 | 2019-12-10 | Haemonetics Corporation | Detection and classification of an anticoagulant using a clotting assay |
| US10676731B2 (en) | 2014-08-19 | 2020-06-09 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating factor IX function |
| KR20250150675A (ko) * | 2014-08-20 | 2025-10-20 | 포톨라 파마슈티컬스, 인코포레이티드 | 인자 xa 해독제용 동결건조된 제형 |
| CN105030703B (zh) * | 2015-06-23 | 2018-03-23 | 上海旭东海普药业有限公司 | 一种防治疗栓塞性疾病的利伐沙班片及其制备方法 |
| US9849125B1 (en) | 2015-11-03 | 2017-12-26 | Banner Lifie Sciences LLC | Anti-overingestion dosage forms |
| CN108883160B (zh) * | 2016-02-24 | 2022-06-28 | 博尔托拉制药公司 | 因子xa解毒剂的冻干制剂 |
| US10640822B2 (en) | 2016-02-29 | 2020-05-05 | Iridia, Inc. | Systems and methods for writing, reading, and controlling data stored in a polymer |
| US10859562B2 (en) | 2016-02-29 | 2020-12-08 | Iridia, Inc. | Methods, compositions, and devices for information storage |
| RU2022101599A (ru) * | 2016-02-29 | 2022-02-25 | Айридия, Инк. | Способы, композиции и устройства для хранения информации |
| US10438662B2 (en) | 2016-02-29 | 2019-10-08 | Iridia, Inc. | Methods, compositions, and devices for information storage |
| TW201802121A (zh) | 2016-05-25 | 2018-01-16 | 諾華公司 | 抗因子XI/XIa抗體之逆轉結合劑及其用途 |
| JP6959268B2 (ja) * | 2016-06-17 | 2021-11-02 | ポートラ ファーマシューティカルズ， インコーポレイテッド | 第ｘａ因子誘導体の調製 |
| WO2018115235A1 (en) | 2016-12-22 | 2018-06-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antidotes to anti-coagulant drugs allowing diagnosis and treatment |
| IL267538B2 (en) | 2016-12-23 | 2024-05-01 | Novartis Ag | Antibodies against factor XI and methods for use in preventing, treating, managing or reducing the risk of thromboembolic disorder or stroke in a patient |
| US10335375B2 (en) | 2017-05-30 | 2019-07-02 | Patheon Softgels, Inc. | Anti-overingestion abuse deterrent compositions |
| CN111246821A (zh) * | 2017-08-21 | 2020-06-05 | 美国绿阳生物技术及医药公司 | 光吸收组合物和使用方法 |
| US11787874B2 (en) | 2017-11-15 | 2023-10-17 | Novo Nordisk A/S | Factor X binders enhancing FX activation |
| WO2019246094A1 (en) * | 2018-06-19 | 2019-12-26 | Portola Pharmaceuticals, Inc. | Antidotes to factor xa inhibitors |
| BR112021002675A2 (pt) * | 2018-08-14 | 2021-05-11 | Jiangsu Hengrui Medicine Co., Ltd. | composições farmacêuticas, métodos para preparar as referidas composições e uso das mesmas |
| EP3920963A4 (en) | 2019-02-07 | 2022-11-30 | Alexion Pharmaceuticals, Inc. | Methods for treating intracranial hemorrhage and assessing efficacy |
| US11655465B1 (en) | 2019-05-02 | 2023-05-23 | Iridia, Inc. | Enzymes and systems for synthesizing DNA |
| ES3033092T3 (en) | 2019-08-08 | 2025-07-30 | Alexion Pharma Inc | Compositions and methods for preparing factor xa and derivatives |
| CN115697493A (zh) * | 2020-06-16 | 2023-02-03 | 阿雷克森制药公司 | 用于测试安得塞奈效力的方法 |
| US11837302B1 (en) | 2020-08-07 | 2023-12-05 | Iridia, Inc. | Systems and methods for writing and reading data stored in a polymer using nano-channels |
| ES3020087T3 (en) | 2020-09-21 | 2025-05-21 | Instr Laboratory Co | Detecting and monitoring oral anticoagulants or intravenous direct thrombin inhibitors in a blood sample |
| CN113484386B (zh) * | 2021-05-21 | 2024-02-13 | 郑州轻工业大学 | 一种金属聚酞菁纳米材料的制备方法及其应用，适配体传感器及其制备方法 |
| CN114681597A (zh) * | 2022-03-11 | 2022-07-01 | 兆科药业（合肥）有限公司 | 蝰蛇蛇毒血凝酶在制备用于逆转凝血因子Xa抑制剂的抗凝作用的药物中的应用 |
| CN116327627B (zh) * | 2023-03-10 | 2024-06-07 | 四川大学 | 一种四面体框架核酸-光甘草定复合物及其在皮肤美白方面的用途 |
Family Cites Families (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH596313A5 (https=) * | 1975-05-30 | 1978-03-15 | Battelle Memorial Institute | |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| GB2183661B (en) | 1985-03-30 | 1989-06-28 | Marc Ballivet | Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US5837249A (en) | 1985-04-19 | 1998-11-17 | The Wistar Institute | Method for generating an immunogenic T cell response protective against a virus |
| US4818700A (en) | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US4812405A (en) | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4704692A (en) | 1986-09-02 | 1987-11-03 | Ladner Robert C | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
| EP0279582A3 (en) | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
| US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
| US6270961B1 (en) | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
| US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5120537A (en) * | 1989-06-14 | 1992-06-09 | Oklahoma Medical Research Foundation | Factor xa based anticoagulant compositions |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5686073A (en) | 1990-05-23 | 1997-11-11 | The University Of Iowa Research Foundation | Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein |
| EP0542810A1 (en) | 1990-08-02 | 1993-05-26 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
| US5278144A (en) * | 1990-09-04 | 1994-01-11 | Cor Therapeutics, Inc. | Antithrombosis agents |
| US5597799A (en) * | 1990-09-04 | 1997-01-28 | Cor Therapeutics, Inc. | Recombinant agents affecting thrombosis |
| US5583107A (en) * | 1990-09-04 | 1996-12-10 | Cor Therapeutics, Inc. | Agents affecting thrombosis and hemostasis |
| WO1992013878A2 (en) | 1991-02-07 | 1992-08-20 | Board Of Trustees Of The University Of Illinois | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| US6797492B2 (en) | 1991-05-17 | 2004-09-28 | Merck & Co., Inc. | Method for reducing the immunogenicity of antibody variable domains |
| WO1993006126A1 (en) | 1991-09-13 | 1993-04-01 | Chiron Corporation | Immunoreactive hepatitis c virus polypeptide compositions |
| WO1993009804A1 (en) | 1991-11-18 | 1993-05-27 | The Scripps Research Institute | Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation |
| DE69232137T2 (de) | 1991-11-25 | 2002-05-29 | Enzon Inc | Multivalente antigen-bindende proteine |
| EP1291360A1 (en) | 1991-12-13 | 2003-03-12 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| DE4203965A1 (de) | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
| JPH07507769A (ja) | 1992-03-20 | 1995-08-31 | コアー・セラピュティックス・インコーポレーテッド | Ｘ因子のグリコシル化媒介による阻害 |
| ES2249761T3 (es) | 1993-06-24 | 2006-04-01 | Advec Inc. | Vectores de adenovirus para terapia genica. |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| EP1637608B1 (en) | 1993-10-25 | 2009-07-22 | CANJI, Inc. | Recombinant adenoviral vector and methods of use |
| US5455338A (en) | 1993-11-05 | 1995-10-03 | Zymogenetics, Inc. | DNA encoding novel human kunitz-type inhibitors and methods relating thereto |
| US5952172A (en) | 1993-12-10 | 1999-09-14 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
| DE4430205A1 (de) | 1994-08-26 | 1996-02-29 | Behringwerke Ag | Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung |
| US5589571A (en) * | 1994-10-28 | 1996-12-31 | Cor Therapeutics, Inc. | Process for production of inhibited forms of activated blood factors |
| AT404357B (de) | 1995-06-13 | 1998-11-25 | Immuno Ag | Prothrombin-derivate |
| US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
| US5955349A (en) | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
| DE19605126A1 (de) * | 1996-02-12 | 1997-08-14 | Basf Ag | Thrombinmuteine als Antidot für Thrombininhibitoren |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| US6200955B1 (en) | 1996-06-11 | 2001-03-13 | Commonwealth Biotechnologies, Inc. | Heparin binding peptides |
| US5736383A (en) | 1996-08-26 | 1998-04-07 | Zymogenetics, Inc. | Preparation of Pichia methanolica auxotrophic mutants |
| US6709659B1 (en) | 1996-08-02 | 2004-03-23 | Zymogenetics, Inc. | Antibodies that bind testis-specific insulin homolog polypeptides |
| SE9604744D0 (sv) * | 1996-12-20 | 1996-12-20 | Pharmacia & Upjohn Ab | A modified coagulation agent |
| AT405517B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-deletionsmutanten und analoge davon |
| AT405516B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
| AU6673898A (en) * | 1997-03-07 | 1998-09-22 | Washington University | Factor x variant |
| JPH1149800A (ja) * | 1997-06-05 | 1999-02-23 | Fujimori Kogyo Kk | アンヒドロトロンビンの合成方法 |
| ES2434961T5 (es) | 1998-04-20 | 2018-01-18 | Roche Glycart Ag | Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo |
| US6322788B1 (en) | 1998-08-20 | 2001-11-27 | Stanley Arthur Kim | Anti-bacterial antibodies and methods of use |
| AU1728800A (en) | 1998-11-18 | 2000-06-05 | Genentech Inc. | Antibody variants with higher binding affinity compared to parent antibodies |
| AU3629800A (en) * | 1999-03-16 | 2000-10-04 | Children's Hospital Of Philadelphia, The | Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors |
| US6624141B1 (en) | 1999-03-17 | 2003-09-23 | The Regents Of The University Of Michigan | Protamine fragment compositions and methods of use |
| US6258559B1 (en) | 1999-03-22 | 2001-07-10 | Zymogenetics, Inc. | Method for producing proteins in transformed Pichia |
| US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US6858599B2 (en) | 1999-06-30 | 2005-02-22 | Mochida Pharmaceutical Co., Ltd. | Tricyclic compound having spiro union |
| AT411997B (de) * | 1999-09-14 | 2004-08-26 | Baxter Ag | Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate |
| EP1095933A1 (en) * | 1999-10-30 | 2001-05-02 | Aventis Pharma Deutschland GmbH | Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| AU2001250783A1 (en) | 2000-02-29 | 2001-09-12 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| WO2001068605A1 (en) * | 2000-03-13 | 2001-09-20 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| JP2004509617A (ja) | 2000-09-08 | 2004-04-02 | シェーリング コーポレイション | 哺乳動物遺伝子；関連試薬および方法 |
| US7070740B1 (en) | 2000-09-28 | 2006-07-04 | Beckman Coulter, Inc. | Method and apparatus for processing biomolecule arrays |
| US20030064414A1 (en) * | 2001-03-30 | 2003-04-03 | Benecky Michael J. | Rapid assessment of coagulation activity in whole blood |
| US7138506B2 (en) | 2001-05-09 | 2006-11-21 | Genetic Id, Na, Inc. | Universal microarray system |
| US6989267B2 (en) | 2001-07-02 | 2006-01-24 | Agilent Technologies, Inc. | Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films |
| DE10155075A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Cyclische Sulfonamide |
| US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
| CN1480466A (zh) * | 2002-09-03 | 2004-03-10 | �й������ž�����ҽѧ��ѧԺ����ҽ | 一类溶栓抗凝双功能融合蛋白及应用 |
| US20040198660A1 (en) * | 2002-11-06 | 2004-10-07 | Petersen Lars Christian | Tissue factor antagonist and protein C polypeptide compositions |
| US7247654B2 (en) * | 2003-06-04 | 2007-07-24 | Bristol-Myers Squibb Company | 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
| EP1723422A2 (en) | 2004-03-05 | 2006-11-22 | The Scripps Research Institute | High throughput glycan microarrays |
| JP4441336B2 (ja) | 2004-06-11 | 2010-03-31 | 日本碍子株式会社 | マイクロアレイの製造方法 |
| US9223929B2 (en) | 2005-03-14 | 2015-12-29 | The California Institute Of Technology | Method and apparatus for detection, identification and quantification of single-and multi-analytes in affinity-based sensor arrays |
| US7119179B1 (en) | 2005-03-21 | 2006-10-10 | Los Alamos National Security, Llc | Preparation of high nitrogen compound and materials therefrom |
| WO2006102687A1 (en) | 2005-03-22 | 2006-09-28 | The Trustees Of Columbia University In The City Of New York | A liposome-based microarray and methods of use thereof |
| NZ592533A (en) | 2005-11-08 | 2012-08-31 | Millennium Pharm Inc | METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR |
| MX336958B (es) | 2005-11-15 | 2016-02-05 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
| US20070111322A1 (en) | 2005-11-15 | 2007-05-17 | Lin-Cheng Yang | Novel method of using inject printing for creating microarrays |
| EP1820508A1 (en) * | 2006-02-21 | 2007-08-22 | CSL Behring GmbH | Coagulation factor X polypeptides with modified activation properties |
| KR102069498B1 (ko) * | 2007-09-28 | 2020-01-23 | 포톨라 파마슈티컬스, 인코포레이티드 | 인자 Ｘａ 저해제에 대한 안티도트 및 그것을 사용하는 방법 |
| EP2364165B1 (en) | 2008-11-14 | 2018-01-03 | Portola Pharmaceuticals, Inc. | Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents |
| KR20110114587A (ko) | 2008-12-19 | 2011-10-19 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 세린 프로테아제 유도체 및 혈액응고 장애의 치료 또는 예방의 용도 |
| PL3604510T3 (pl) * | 2009-03-30 | 2025-07-28 | Alexion Pharmaceuticals, Inc. | Antidota na inhibitory czynnika xa i sposoby ich stosowania |
| PT2453910T (pt) | 2009-07-15 | 2016-12-07 | Portola Pharm Inc | Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento |
-
2008
- 2008-09-26 KR KR1020167003860A patent/KR102069498B1/ko active Active
- 2008-09-26 KR KR1020177023761A patent/KR20170100071A/ko not_active Ceased
- 2008-09-26 CN CN2008801079738A patent/CN101802188B/zh active Active
- 2008-09-26 HU HUE08834136A patent/HUE031647T2/en unknown
- 2008-09-26 PL PL14197779T patent/PL2915564T3/pl unknown
- 2008-09-26 CN CN201110447251.0A patent/CN102559644B/zh active Active
- 2008-09-26 HU HUE14197779A patent/HUE052423T2/hu unknown
- 2008-09-26 EP EP08834136.7A patent/EP2193196B1/en active Active
- 2008-09-26 SI SI200832153T patent/SI2915564T1/sl unknown
- 2008-09-26 DK DK16167534.3T patent/DK3078743T3/da active
- 2008-09-26 JP JP2010527220A patent/JP5637561B2/ja active Active
- 2008-09-26 BR BRPI0816837-7A patent/BRPI0816837B1/pt active IP Right Grant
- 2008-09-26 KR KR1020207001549A patent/KR102271404B1/ko active Active
- 2008-09-26 PT PT141977793T patent/PT2915564T/pt unknown
- 2008-09-26 AU AU2008304192A patent/AU2008304192B9/en active Active
- 2008-09-26 CN CN2011104472050A patent/CN102533702A/zh active Pending
- 2008-09-26 PL PL16167534T patent/PL3078743T3/pl unknown
- 2008-09-26 SI SI200832130T patent/SI3078743T1/sl unknown
- 2008-09-26 KR KR1020107008718A patent/KR101698214B1/ko active Active
- 2008-09-26 SG SG2012072716A patent/SG185263A1/en unknown
- 2008-09-26 BR BR122022001846-7A patent/BR122022001846B1/pt active IP Right Grant
- 2008-09-26 DK DK14197779.3T patent/DK2915564T3/da active
- 2008-09-26 PT PT161675343T patent/PT3078743T/pt unknown
- 2008-09-26 EP EP14197779.3A patent/EP2915564B1/en active Active
- 2008-09-26 ES ES08834136.7T patent/ES2597436T3/es active Active
- 2008-09-26 EP EP16167534.3A patent/EP3078743B1/en active Active
- 2008-09-26 EP EP20198287.3A patent/EP3824902A1/en not_active Withdrawn
- 2008-09-26 PT PT88341367T patent/PT2193196T/pt unknown
- 2008-09-26 CN CN201310301566.3A patent/CN103446579B/zh active Active
- 2008-09-26 HU HUE16167534A patent/HUE050063T2/hu unknown
- 2008-09-26 ES ES16167534T patent/ES2796623T3/es active Active
- 2008-09-26 DK DK08834136.7T patent/DK2193196T3/en active
- 2008-09-26 US US12/239,651 patent/US8153590B2/en active Active
- 2008-09-26 LT LTEP08834136.7T patent/LT2193196T/lt unknown
- 2008-09-26 CA CA2697583A patent/CA2697583C/en active Active
- 2008-09-26 LT LTEP16167534.3T patent/LT3078743T/lt unknown
- 2008-09-26 SI SI200831678A patent/SI2193196T1/sl unknown
- 2008-09-26 WO PCT/US2008/078014 patent/WO2009042962A2/en not_active Ceased
- 2008-09-26 HR HRP20161255TT patent/HRP20161255T1/hr unknown
- 2008-09-26 ES ES14197779T patent/ES2849426T3/es active Active
- 2008-09-26 NZ NZ583944A patent/NZ583944A/en unknown
- 2008-09-26 MX MX2010003095A patent/MX2010003095A/es active IP Right Grant
- 2008-09-26 PL PL08834136T patent/PL2193196T3/pl unknown
-
2010
- 2010-02-16 IL IL203993A patent/IL203993A/en active IP Right Grant
- 2010-03-23 ZA ZA2010/02039A patent/ZA201002039B/en unknown
-
2012
- 2012-03-07 US US13/414,499 patent/US8455441B2/en active Active
-
2013
- 2013-04-11 AU AU2013205326A patent/AU2013205326A1/en not_active Abandoned
- 2013-05-07 US US13/889,014 patent/US9062298B2/en active Active
- 2013-06-11 US US13/915,525 patent/US8889129B2/en active Active
-
2014
- 2014-07-21 US US14/337,074 patent/US9388401B2/en active Active
- 2014-08-07 AU AU2014210620A patent/AU2014210620B2/en active Active
- 2014-08-19 JP JP2014166333A patent/JP6047127B2/ja active Active
- 2014-09-04 ZA ZA2014/06514A patent/ZA201406514B/en unknown
-
2016
- 2016-06-08 US US15/176,461 patent/US10675335B2/en active Active
- 2016-10-12 CY CY20161101020T patent/CY1118482T1/el unknown
- 2016-11-18 JP JP2016225290A patent/JP6300885B2/ja active Active
-
2017
- 2017-01-12 AU AU2017200212A patent/AU2017200212A1/en not_active Abandoned
- 2017-11-02 IL IL255397A patent/IL255397B/en active IP Right Grant
-
2018
- 2018-02-27 JP JP2018033229A patent/JP2018100290A/ja active Pending
-
2019
- 2019-02-18 IL IL264886A patent/IL264886B/en active IP Right Grant
- 2019-06-13 AU AU2019204123A patent/AU2019204123A1/en not_active Abandoned
- 2019-11-08 NO NO2019040C patent/NO2019040I1/no unknown
-
2020
- 2020-02-26 IL IL272926A patent/IL272926A/en unknown
- 2020-03-12 JP JP2020042919A patent/JP2020109113A/ja active Pending
- 2020-05-07 US US16/869,117 patent/US11839646B2/en active Active
- 2020-07-08 HR HRP20201071TT patent/HRP20201071T1/hr unknown
- 2020-08-04 CY CY20201100715T patent/CY1123504T1/el unknown
- 2020-09-09 NL NL301063C patent/NL301063I2/nl unknown
- 2020-09-23 NO NO2020033C patent/NO2020033I1/no unknown
- 2020-09-23 FR FR20C1045C patent/FR20C1045I2/fr active Active
- 2020-12-16 CY CY2020042C patent/CY2020042I2/el unknown
- 2020-12-22 LT LTPA2020540C patent/LTC3078743I2/lt unknown
- 2020-12-22 HU HUS2000057C patent/HUS2000057I1/hu unknown
-
2021
- 2021-08-17 AU AU2021218033A patent/AU2021218033A1/en not_active Abandoned
-
2022
- 2022-07-29 JP JP2022121451A patent/JP2022153574A/ja active Pending
-
2023
- 2023-11-02 US US18/500,675 patent/US20240082367A1/en active Pending
-
2024
- 2024-12-20 AU AU2024287094A patent/AU2024287094A1/en active Pending
-
2025
- 2025-01-21 JP JP2025008426A patent/JP2025063249A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017043632A5 (https=) | ||
| HRP20201071T1 (hr) | Protuotrovi za inhibitore faktora xa i postupci njihove uporabe | |
| FI3604510T3 (fi) | Vastalääkkeitä tekijä xa:n estäjille ja menetelmiä niiden käyttämiseksi | |
| Warkentin | Bivalent direct thrombin inhibitors: hirudin and bivalirudin | |
| FI3227675T3 (fi) | Aktiviini-actrii-antagonisteja ja niiden käyttöjä myelodysplastisen oireyhtymän hoitamiseksi | |
| JP2019194251A5 (https=) | ||
| Kurihara et al. | Endothelin: a potent vasoconstrictor associated with coronary vasospasm | |
| IL274846B2 (en) | Formulation for anti-alpha 4 antibody in cell 7 | |
| JP2015518818A5 (https=) | ||
| JP2017509624A5 (https=) | ||
| JP2010539945A5 (ja) | 第Ｘａ因子阻害剤に対する解毒剤およびその使用の方法 | |
| Gould et al. | Recent advances in the discovery and development of direct coagulation factor Xa inhibitors | |
| JP2015536943A5 (https=) | ||
| JP2012533552A5 (https=) | ||
| Calvete et al. | Could the new rabbit haemorrhagic disease virus variant (RHDVb) be fully replacing classical RHD strains in the Iberian Peninsula? | |
| JP2016506727A5 (https=) | ||
| Schofield et al. | No increase in blood transfusions during liver transplantation since the withdrawal of aprotinin | |
| JP2017533910A5 (https=) | ||
| JP2015508771A5 (https=) | ||
| JP2017532365A5 (https=) | ||
| JP2017525704A5 (https=) | ||
| Fouad | Chronic hepatitis C-associated thrombocytopenia: aetiology and management | |
| JP2016530284A5 (https=) | ||
| RU2015116264A (ru) | Композиции и способы лечения сердечной недостаточности у пациентов с диабетом | |
| SI2576524T1 (en) | USE OF METFORMIN IN COMBINATION WITH GLUCOIN-ACTIVE ACTIVATORS, ALSO THE COMPOSITION, COMPARING METFORMIN AND GLUCOIN-ACTIVE ACTUATOR |